A new class of diabetes medication

October 18, 2006

Can it be hope for Merck? The selling point is no weight gain. Trials show a decrease of 0.77 in A1c over 12 weeks.

Similar Posts:


KevinMD.com on Facebook


{ 1 comment }

1 Esquivel October 18, 2006 at 11:37 am

I’m sure CJD already has his first case written up, and he’s out there hunting for someone’s name to throw on the lawsuit already. :-)

Comments on this entry are closed.

Previous post: "Waste of a mind": Why medical students shun geriatrics

Next post: The inability to take no for an answer

Site Meter